Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 2/1/16  and contains information from public web pages and contributions from the ZoomInfo community.

Dr. Robert H. Ring

Wrong Dr. Robert H. Ring?

Chief Science Officer

Phone: (609) ***-****  
Local Address:  Princeton , New Jersey , United States
Autism Speaks Inc
1 East 33Rd Street 4Th Floor
New York , New York 10016
United States

Company Description: Autism is a general term used to describe a group of complex developmental brain disorders - autism spectrum disorders - caused by a combination of genes and...   more
Background

Employment History

  • Vice President of Translational Research
    Autism Speaks Inc
  • President
    Delivering Scientific Innovation for Autism
  • Chairman
    Delivering Scientific Innovation for Autism
  • Chief Science Officer of Autism Speaks and Head of Autism Research
    Pfizer Inc
  • Member, Autism Research Unit
    Pfizer Inc
  • Senior Director and Head of the Autism Research Unit
    Pfizer Inc
  • Chief Science Officer
    AutismSpeaks.org
  • President and Autism Speaks' Chief Science Officer
    DELSIA
  • President of DELSIA
    DELSIA
  • Chairman of Managers
    DELSIA

Board Memberships and Affiliations

  • Founder
    Delivering Scientific Innovation for Autism

Education

  • Ph.D. , Molecular Neurobiology
    City of Hope National Medical Center
  • B.A. double major , Fine Art and Biology
    Westmont College
  • Ph.D. , Molecular Neurobiology
    City of Hope
  • B.A. degree , Fine Art and Biology
  • PhD
168 Total References
Web References
Leadership | About Us | Autism Speaks
www.autismspeaks.org, 28 May 2014 [cached]
Rob Ring -- Chief Science Officer
...
Rob Ring, Chief Science Officer
Rob Ring was named Chief Science Officer in June of 2013. Upon his appointment Rob said his first goal would be to "put science to work for our families," and that makes perfect sense given his background. Rob first joined Autism Speaks in June of 2011 as Vice President of Translational Research. In that role, Rob was responsible for the development and implementation of the foundation's expanding translational research portfolio, which serves to accelerate the process of converting scientific breakthroughs and innovations in technology into actual products that address the wide range of unmet needs of the autism community, from healthcare to education to daily living. Rob also serves as President of Delivering Scientific Innovation for Autism (DELSIA), the venture philanthropy arm of Autism Speaks that is helping to facilitate translational activities in the for-profit sector required to develop commercial products that will improve the quality of life and health for individuals with autism.
Prior to joining Autism Speaks, Rob served as Senior Director and Head of the Autism Research Unit at Pfizer Worldwide Research and Development in Groton, Conn. There he led the first dedicated research group in the pharmaceutical industry focused specifically on the discovery and development of medicines for neurodevelopmental disorders, specifically ASD. Prior to Pfizer, Rob worked for over 10 years in psychiatric medicines discovery and development at Wyeth Research in Princeton, N.J.
Rob earned a B.A. double major in both Fine Art and Biology from Westmont College in Santa Barbara, Calif., and a Ph.D. in Molecular Neurobiology from City of Hope in Southern California. He holds adjunct faculty appointments in the Departments of Psychiatry at Mount Sinai School of Medicine (N.Y.) and Pharmacology and Physiology at Drexel University College of Medicine (Philadelphia).
Rob Ring, Chief Scientific ...
www.convergeditsummit.com [cached]
Rob Ring, Chief Scientific Officer, Autism Speaks
Dr. Ring currently serves as Chief Science Officer (CSO) for Autism Speaks, role he has held since June of 2013. Autism Speaks is a leading science and advocacy foundation founded in 2005, which has been responsible for funding over $280 million in research into causes, prevention and treatment of autism spectrum disorder (ASD). A neuroscientist by training, Dr. Ring is responsible for leading the science program at Autism Speaks, which is focused on ‘putting scientific breakthroughs to work for families.’ This program at Autism Speaks features a diverse portfolio of research investments targeting etiology & environmental science, medical research, public health, innovative technologies, and genomic discovery. As CSO, Dr. Ring has specifically helped launch Autism Speaks signature genomics discovery program, MSSNG (aka ‘Aut10K’ program), which has partnered with Google to develop an unprecedented open-access database of genomic sequence information to support the autism research ecosystem. Dr. Ring joined Autism Speaks in 2011 as vice president and Head of Translational Research. In this previous role, Dr. Ring was responsible for launching the foundation’s innovative venture philanthropy arm Delivering Scientific Innovation for Autism (aka ‘DELSIA’), which support entrepreneurs and early stage companies developing products that address unmet needs of the ASD community. Dr. Ring has served as a public member of the Interagency Autism Coordinating Committee (IACC), the federal advisory committee that coordinates all efforts within the Department of Health and Human Services (HHS) concerning ASD. Prior to joining Autism Speaks, Dr. Ring was a Senior Director and Head of the Autism Research Unit at Pfizer Worldwide Research and Development in Groton, Connecticut. It was there he led the first dedicated research group in the pharmaceutical industry focused specifically on the discovery and development of medicines for neurodevelopmental disorders, specifically Autism Spectrum Disorders. Prior to Pfizer, Dr. Ring distinguished worked for over 10 years in psychiatric medicines discovery and development at Wyeth Research in Princeton, NJ. Dr. Ring holds separate adjunct faculty appointments in the Department of Psychiatry at Mount Sinai School of Medicine (New York) and Department of Pharmacology and Physiology at Drexel University College of Medicine (Philadelphia).
Autism Speaks | Left Brain Right Brain
leftbrainrightbrain.co.uk [cached]
The Wright family is, at least, sympathetic to the idea that vaccines cause autism (and, in at least one case, very outspoken on the idea.) So perhaps I should have been surprised when Autism Speaks put on their website Rob Ring's statement together with a statement by Bob Wright.
...
Rob Ring Chief Science Officer, Autism Speaks
...
First, here is a statement by Robert Ring, Chief Science Officer:
Over the last two decades, extensive research has asked whether there is any link between childhood vaccinations and autism. The results of this research are clear: Vaccines do not cause autism. We urge that all children be fully vaccinated.
Rob Ring Chief Science Officer, Autism Speaks
...
The above statement by Mr. Ring was picked up by the press in February as it was so clear.
...
It comes across as though Mr. Wright is trying to appear to ride the fence while at the same time pulling back dramatically from the clear statement by Mr. Ring.
...
The new members are Wendy Chung from Simons Foundation and Robert Ring from Autism Speaks.
...
The Department of Health and Human Services today announced the appointments of Wendy Chung, M.D., Ph.D., and Robert Ring, Ph.D., as public members of the Interagency Autism Coordinating Committee (IACC), a federal advisory Committee composed of federal agency officials and appointed community stakeholders that provides coordination and a forum for public input on issues related to autism spectrum disorder (ASD).
...
Prior to her departure, former HHS Secretary Kathleen Sebelius appointed Dr. Chung, Director of Clinical Research for the Simons Foundation Autism Research Initiative (SFARI), and Dr. Ring, Chief Science Officer of Autism Speaks, to join the IACC in order to provide additional perspectives and expertise to the Committee.
...
Dr. Chung and Dr. Ring serve as leaders within the two organizations that are the largest private funders of autism research in the United States.
...
Dr. Ring, who has been the Chief Science Officer of Autism Speaks since 2013, also serves as the Chairman of the Board of Delivering Scientific Innovation for Autism (DELSIA), the venture philanthropy arm of Autism Speaks, and leads Autism Speaks' collaboration with the Simons Foundation to launch the Autism BrainNet, a privately-funded multisite brain banking effort focused on supporting autism research. Dr. Ring previously served as Autism Speaks' Vice President of Translational Research. He holds adjunct faculty appointments in the Departments of Psychiatry at Mount Sinai School of Medicine and Pharmacology and Physiology at Drexel University College of Medicine. Prior to his work at Autism Speaks, Dr. Ring served as Senior Director and Head of the Autism Research Unit at Pfizer Worldwide Research and Development and worked in the area of psychiatric drug discovery at Wyeth Research.
The Braff Group - The Big Investment Opportunity...in Autism?
www.thebraffgroup.com, 2 Mar 2014 [cached]
"We see a real possibility to align the creation of value for investors with the creation of value for families in the autism space," said Robert Ring, chief science officer of Autism Speaks and former head of autism research at Pfizer.
As part of the new therapeutics ...
www.eurekalert.org, 1 Nov 2010 [cached]
As part of the new therapeutics initiative, the first session of the afternoon brought together speakers representing clinical trials for therapeutics in three autism-related disorders: Rett Syndrome, Tuberous Sclerosis and Fragile X. Capitalizing on this opportunity, Robert Ring, PhD, the Senior Director and Head of the newly established Autism Research Unit within Pfizer Global Research and Development spoke about how academia and the pharmaceutical industry can leverage collaboration in the pursuit of autism therapeutics.
"The future of therapeutic discovery and development for patients living with autism cannot be built without a strong foundation of collaborative partnership between industry and academia," said Dr. Ring.
...
The first afternoon session, lead by Mriganka Sur, PhD, Newton Professor of Neuroscience, and Head of the Department of Brain and Cognitive Sciences at MIT, included updates on clinical trials in disorders related to autism, as well as a discussion on collaborations between academia and industry, led by Robert Ring, PhD, Senior Director and Head of the Autism Research Unit at Pfizer Global Research and Development.
Other People with the name "Ring":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.
zirhbt201304